Hauri, S.; Jakubiak, P.; Fueth, M.; Dengl, S.; Belli, S.; Alvarez-Sánchez, R.; Caruso, A.
Understanding the Half-Life Extension of Intravitreally Administered Antibodies Binding to Ocular Albumin. Pharmaceutics 2020, 12, 810.
https://doi.org/10.3390/pharmaceutics12090810
AMA Style
Hauri S, Jakubiak P, Fueth M, Dengl S, Belli S, Alvarez-Sánchez R, Caruso A.
Understanding the Half-Life Extension of Intravitreally Administered Antibodies Binding to Ocular Albumin. Pharmaceutics. 2020; 12(9):810.
https://doi.org/10.3390/pharmaceutics12090810
Chicago/Turabian Style
Hauri, Simon, Paulina Jakubiak, Matthias Fueth, Stefan Dengl, Sara Belli, Rubén Alvarez-Sánchez, and Antonello Caruso.
2020. "Understanding the Half-Life Extension of Intravitreally Administered Antibodies Binding to Ocular Albumin" Pharmaceutics 12, no. 9: 810.
https://doi.org/10.3390/pharmaceutics12090810
APA Style
Hauri, S., Jakubiak, P., Fueth, M., Dengl, S., Belli, S., Alvarez-Sánchez, R., & Caruso, A.
(2020). Understanding the Half-Life Extension of Intravitreally Administered Antibodies Binding to Ocular Albumin. Pharmaceutics, 12(9), 810.
https://doi.org/10.3390/pharmaceutics12090810